Disconnected systems – not a lack of technology – are slowing clinical trial execution and forcing site staff to bridge costly workflow gaps.
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- What Will Life Science Orgs Do When The AI Bill Comes Through?
- Clinical Trial Standards — What They Are And Why They're Indispensable
- The Data Was Already There: RWE's Real Bottleneck Is People
- Two Planning Mistakes That Quietly Sink Clinical Programs
- Duplicate Tech, Not Technology, Is Burning Out Trial Sites
- The Real Reason Clinical Trial Systems Don't Talk To Each Other
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
One Day, Clinical Trials Will Represent The Real World
What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
Why eSource Ensures Data Integrity In Medical Device Clinical Trials
Learn how eSource data capture offers a more efficient and cost-effective approach to maintaining data integrity.
-
EU Annex 11: How To Stay Compliant
EU Annex 11 lays out the European Union’s regulations for using computerized systems during clinical trials. Learn how sponsors and sites seeking treatment approval in the EU must follow Annex 11.
-
Guide: How Connected Devices Improve Clinical Trial Data
Gain an overview of how and why connected devices provide sponsors and CROs with better clinical trial data, and offer patients much better trial experiences!
-
Could ePRO Be The New Standard In Health Reimbursement?
Recently, early-phase protocols have been collecting patient-reported outcomes (PROs) not only to get regulatory approval but to demonstrate value to public and private payers.
-
Is Your Legacy EDC Limiting AI's Impact On Your Clinical Data?
AI can enhance clinical data workflows, but aging EDC systems hold teams back. This piece breaks down key barriers and shows what’s needed to modernize data foundations for meaningful AI adoption.
-
Virtual eConsent For Decentralized Trials
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Training Program Reduces Placebo Effect By More Than 50% In ePRO Study
Discover how an instruction program directly contributed to significantly lowering the placebo response rate in a phase III migraine CNS study.
-
EDC Powers End-To-End Data Management In Pharma-Sponsored Trials
As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
NeuraLace Doubles Clinical Trial Enrollment & Improves Participant Compliance With EDC & ePRO
Find out how one company dedicated to producing innovative non-invasive chronic pain therapies was able to engage its patients in new ways.
- Clinical Trial Sites Don't Need More Tech, They Need Fewer Silos
- A Biostatistician's Caution Around Digital Twins In Trials
- Who Owns Data Quality? The Authority Gap Slowing Trials
- Clinical Research Isn't Even A Recognized Job. That's A Problem.
- The Data Was Already There: RWE's Real Bottleneck Is People
RECENT NEWSLETTERS
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
- 09.10.26 -- AI, Trial Costs, And RTSM Are Reshaping Clinical Operations
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality